Telmisartan CAS 144701-48-4

Identification Properties Safety Data Specifications & Other Information Links

Identification

CAS Number

144701-48-4

Name

Telmisartan

Synonyms

[1,1′-Biphenyl]-2-carboxylic acid, 4′-[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]- [ACD/Index Name] 144701-48-4 [RN] 4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]-2-biphenylcarbonsäure [German] [ACD/IUPAC Name] 4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]-2-biphenylcarboxylic acid [ACD/IUPAC Name] 4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carbonsäure [German] 4′-[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carboxylic acid 7144 Acide 4′-[(1,7′-diméthyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)méthyl]-2-biphénylcarboxylique [French] [ACD/IUPAC Name] acide 4′-[(1,7′-diméthyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)méthyl]biphényl-2-carboxylique [French] Kinzalmono [Trade name] Micardis [Trade name] Pritor [Trade name] telmisartan [French] [INN] Telmisartan [INN] [JAN] [USAN] [Wiki] telmisartán [Spanish] [INN] telmisartanum [Latin] [INN] U5SYW473RQ телмисартан [Russian] [INN] تيلميسارتان [Arabic] [INN] 替米沙坦 [Chinese] [INN] (1,1′-Biphenyl)-2-carboxylic acid, 4′-((1,4′-dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl)methyl)- [1,1′-biphenyl]-2-carboxylic acid, 4′[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl] [144701-48-4] 1189889-44-8 [RN] 2-(4-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid 2-[4-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]phenyl]benzoic acid 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid 2-[4-[[4-methyl-6-(1-methylbenzoimidazol-2-yl)-2-propyl-benzoimidazol-1-yl]methyl]phenyl]benzoic acid 4′-((1,4′-dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl)methyl)-(1,1′-biphenyl)-2-carboxylic acid 4-((1,7-dimethyl-2-propyl-1h,3h-[2,5-bibenzo[d]imidazol]-3-yl)methyl)-[1,1-biphenyl]-2-carboxylic acid 4′-((1,7′-dimethyl-2′-propyl-1H,3’H-[2,5′-bibenzo[d]imidazol]-3′-yl)methyl)-[1,1′-biphenyl]-2-carboxylic acid 4′-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid 4-(1,4-Dimethyl-2-propyl-2,6-bi-1H-benzimidazol-1-yl)methyl-1,1-biphenyl-2-carboxylicacid 4′-(1,7′-Dimethyl-2′-propyl-1H-[2,5′]bibenzoimidazolyl-3′-ylmethyl)-biphenyl-2-carboxylic acid 4′-?[(1,?4′-?DIMETHYL-?2′-?PROPYL[2,?6′-?BI-?1H-?BENZIMIDAZOL]-?1′-?YL)METHYL]-?[1,?1′-?BIPHENYL]-?2-?CARBOXYLIC ACID 4′-[(1,4′-dimethyl-2’propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]-[1,1′-biphenyl]-2-carboxylic acid 4′-[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]-[1,1′-biphenyl]-2-carboxylic acid 4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid 4′-[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid 4′-[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid 4-[(1,7-dimethyl-2-propyl-1h,3h-2,5-bibenzimidazol-3-yl)methyl]biphenyl-2-carboxylic acid 4′[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carboxylic acid 4′-[[1,4′-Dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl]-methyl]-1,1′-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester 4′-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid 4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid 6624054 [Beilstein] BAY-68-9291 BIBR 277 SE BIBR 277;Micardis;Pritor;Telday BIBR 277SE BIBR277 BIBR-277SE BIBR-277-SE BR-72892 BSPBio_002738 C33H30N4O2 Carbon monoxide releasing molecule 3 | DV2037500 Kinzal MFCD00918125 [MDL number] Micardis (TN) MICARDIS HCT Micardis® MLS000759432 NCGC00095150-01 NCGC00095150-02 Pharmakon1600-01505261 Pritor® SMR000466326 SPECTRUM1505261 Spectrum5_001053 Targit Targit;Temax;BIBR277;Micardis Telday Teleact D Telma Telmisartan (JAN/USAN/INN) Telmisartan (Micardis) TELMISARTAN-D3 Telmisattan Temax TL8000991 TLS UNII:U5SYW473RQ UNII-U5SYW473RQ

Molecular Structure

SMILES

CCCc1nc2c(cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)O)c5nc6ccccc6n5C)C

StdInChI

InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)

StdInChIKey

RMMXLENWKUUMAY-UHFFFAOYSA-N

Molecular Formula

C33H30N4O2

Molecular Weight

514.62

MDL Number

MFCD00918125

Safety Data

Personal Protective Equipment

Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter

RIDADR

NONH for all modes of transport

WGK Germany

2

Specifications and Other Information of Our Telmisartan CAS 144701-48-4

Standard

EP, USP

GMP

LCFDA

Basic Patent Situation

US expiry date	20140107
EU expiry date	20120131 (20170130)
JP expiry date	20170125

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

Used as the Angiotensin II Receptor Antagonist.

Links

This product is developed by our R&D company Watsonnoke Scientific Ltd(http://www.watsonnoke.com/), and here is the corresponding linkhttp://www.watsonnoke.com/telmisartan-cas-144701-48-4/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly (Please change screen to horizontal for complete browsing if you are checking Watson on your mobile phone).